Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rivera

Showing results (1421-1430 of 1,448) with videos related to

Pageof 145
Sort By:
Blood|March 24, 2018
Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trialJorge E Cortes, Dong-Wook Kim, Javier Pinilla-Ibarz, et al.
Neurology|December 8, 2010
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER StudyR K Heaton, D B Clifford, D R Franklin, et al.
Cancer Cell|November 3, 2009
AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistanceThomas O'Hare, William C Shakespeare, Xiaotian Zhu, et al.
Cell Host & Microbe|May 12, 2017
Global Reprogramming of Host Kinase Signaling in Response to Fungal InfectionAseem Pandey, Sheng Li Ding, Qing-Ming Qin, et al.
Bioorganic & Medicinal Chemistry Letters|May 13, 2011
Discovery of 5-(arenethynyl) hetero-monocyclic derivatives as potent inhibitors of BCR-ABL including the T315I gatekeeper mutantMathew Thomas, Wei-Sheng Huang, David Wen, et al.
Cell|March 15, 2024
Type-I-interferon-responsive microglia shape cortical development and behaviorCaroline C Escoubas, Leah C Dorman, Phi T Nguyen, et al.
Journal of Medicinal Chemistry|May 5, 2016
Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma KinaseWei-Sheng Huang, Shuangying Liu, Dong Zou, et al.
Multiple Sclerosis and Related Disorders|February 15, 2025
Central American and Caribbean consensus for the treatment of MS, NMOSD, and MOGADDeyanira A Ramirez, Fernando Gracia, Alejandro J Diaz Jimenez, et al.
The New England Journal of Medicine|November 5, 2013
A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemiasJ E Cortes, D-W Kim, J Pinilla-Ibarz, et al.
Annals of the American Thoracic Society|September 29, 2023
Diversity, Equity, and Inclusion in the Pediatric Pulmonary Workforce: An Official American Thoracic Society Workshop ReportNicole Stephenson, Erick Forno, Theresa A Laguna, et al.
Pageof 145

Showing results (1421-1430 of 1,448) with videos related to

Sort By:
Pageof 145
Blood|March 24, 2018
Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trialJorge E Cortes, Dong-Wook Kim, Javier Pinilla-Ibarz, et al.
Neurology|December 8, 2010
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER StudyR K Heaton, D B Clifford, D R Franklin, et al.
Cancer Cell|November 3, 2009
AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistanceThomas O'Hare, William C Shakespeare, Xiaotian Zhu, et al.
Cell Host & Microbe|May 12, 2017
Global Reprogramming of Host Kinase Signaling in Response to Fungal InfectionAseem Pandey, Sheng Li Ding, Qing-Ming Qin, et al.
Bioorganic & Medicinal Chemistry Letters|May 13, 2011
Discovery of 5-(arenethynyl) hetero-monocyclic derivatives as potent inhibitors of BCR-ABL including the T315I gatekeeper mutantMathew Thomas, Wei-Sheng Huang, David Wen, et al.
Cell|March 15, 2024
Type-I-interferon-responsive microglia shape cortical development and behaviorCaroline C Escoubas, Leah C Dorman, Phi T Nguyen, et al.
Journal of Medicinal Chemistry|May 5, 2016
Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma KinaseWei-Sheng Huang, Shuangying Liu, Dong Zou, et al.
Multiple Sclerosis and Related Disorders|February 15, 2025
Central American and Caribbean consensus for the treatment of MS, NMOSD, and MOGADDeyanira A Ramirez, Fernando Gracia, Alejandro J Diaz Jimenez, et al.
The New England Journal of Medicine|November 5, 2013
A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemiasJ E Cortes, D-W Kim, J Pinilla-Ibarz, et al.
Annals of the American Thoracic Society|September 29, 2023
Diversity, Equity, and Inclusion in the Pediatric Pulmonary Workforce: An Official American Thoracic Society Workshop ReportNicole Stephenson, Erick Forno, Theresa A Laguna, et al.
Pageof 145